Copernicus Therapeutics Incorporated Company Profile

18:38 EDT 23rd March 2018 | BioPortfolio

Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Western Reserve University that provide the foundation for the use of DNA as drugs.Copernicus is not involved in gene discovery or the linkage of genetic defects to disease. Copernicus' business focuses on using its technologies to make and sell gene therapy products to treat, cure or prevent human diseases - products that work.


11000 Cedar Avenue, Suite 120
United States of America


Phone: 216-231-0227
Fax: 216-231-9477

News Articles [733 Associated News Articles listed on BioPortfolio]

WIRB-Copernicus Group acquires Vigilare International

WIRB Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of Vigilare International, a provider of integra...

WIRB-Copernicus Group partners with Veeva Systems

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, is partnering with Veeva Systems to improve the speed and accuracy of ins...

WCG acquires pharmacovigilance firm Vigilare

WIRB Copernicus Group (WCG) has expanded its portfolio of companies to include the pharmacovigilance and drug safety solution provider Vigilare International.

WCG acquires Vigilare International

WIRB Copernicus Group (WCG) has acquired a provider of integrated end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry, Vigilare International.

Copernicus Plans Liberal Licensing for its Advanced DNA Delivery Technology

Imagine, for a moment, that every drug on the market suddenly didn’t work because of the lack of an adequate delivery system. That’s precisely the situation gene therapy companies find themselves ...

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

Global Veterinary Therapeutics Market to Mark CAGR of 6.0% Over Next 10 Years - announces publication of its recently generated research report titled, "GlobalVeterinary Therapeutics MarketBy Type (Therapeutics Drugs, Therapeutics Vaccines, Feed Additives The...

EMRs are robbing physicians of their writing skills

Many physicians have become world famous writers, and in Greek mythology, Apollo was the god of both poetry and medicine. I can personally think of many prominent physician writers I have come across ...

PubMed Articles [408 Associated PubMed Articles listed on BioPortfolio]

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Introduction to Volume 2 of JOPT Special Issue.

Eyes on New Product Development: Preclinical Research.

Introduction to Volume 1 of JOPT Special Issue.

Clinical Trials [135 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1236 Associated Companies listed on BioPortfolio]

Copernicus Therapeutics Incorporated

Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Wester...

Copernicus Therapeutics, Inc.

Copernicus' Management and Board of Directors have experience in company management, pharmaceutical/biotechnology R&D, clinical development, and finance.

Copernicus Group IRB

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review board...


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Copernicus Therapeutics Incorporated" on BioPortfolio

We have published hundreds of Copernicus Therapeutics Incorporated news stories on BioPortfolio along with dozens of Copernicus Therapeutics Incorporated Clinical Trials and PubMed Articles about Copernicus Therapeutics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Copernicus Therapeutics Incorporated Companies in our database. You can also find out about relevant Copernicus Therapeutics Incorporated Drugs and Medications on this site too.

Quick Search


Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Corporate Database Quicklinks

Searches Linking to this Company Record